June 3 (Reuters) - Evolent Health Inc EVH.N:
REAFFIRMS 2025 REVENUE GUIDANCE OF $2.06 BILLION TO $2.11 BILLION - SEC FILING
REAFFIRMS Q2 2025 REVENUE GUIDANCE OF $440 MILLION TO $470 MILLION - SEC FILING
FY2025 REVENUE VIEW $2.05 BILLION -- LSEG IBES DATA
Q2 REVENUE VIEW $459.4 MILLION -- LSEG IBES DATA
Source text: [ID:n0001628908-25-000069]
Further company coverage: EVH.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.